(+/-)-2-t-butoxycarbonylamino-5-[2-chloro-4-(3-trifluoromethylphenylthio)phenyl]-2-methylpentan-1-ol | 1006727-24-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (+/-)-2-t-butoxycarbonylamino-5-[2-chloro-4-(3-trifluoromethylphenylthio)phenyl]-2-methylpentan-1-ol
• 英文别名: tert-butyl N-[5-[2-chloro-4-[3-(trifluoromethyl)phenyl]sulfanylphenyl]-1-hydroxy-2-methylpentan-2-yl]carbamate
• CAS: 1006727-24-7
• 化学式: C₂₄H₂₉ClF₃NO₃S
• 分子量: 504.013
• InChiKey: UGFBTAQMNLXVTH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.7
• 重原子数：
  33
• 可旋转键数：
  10
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  83.9
• 氢给体数：
  2
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  二碳酸二叔丁酯 、 (-)-2-amino-5-[2-chloro-4-(3-trifluoromethylphenylthio)phenyl]-2-methylpentan-1-ol 以 1,4-二氧六环 为溶剂， 生成 (+/-)-2-t-butoxycarbonylamino-5-[2-chloro-4-(3-trifluoromethylphenylthio)phenyl]-2-methylpentan-1-ol
  参考文献：
  名称：

  AMINOPHOSPHORIC ACID ESTER DERIVATIVE AND S1P RECEPTOR MODULATOR CONTAINING THE SAME AS ACTIVE INGREDIENT

  摘要：

  公开号：

  EP2058317B1

文献信息

• THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR INFLAMMATORY BOWEL DISEASE COMPRISING AMINO ALCOHOL DERIVATIVE AS ACTIVE INGREDIENT
  申请人：Yamamuro Naoya

  公开号：US20100324057A1

  公开（公告）日：2010-12-23

  A novel therapeutic agent or prophylactic agent for an inflammatory bowel disease is provided. An amino alcohol derivative represented by the general formula (1): which is a sphingosine-1-phosphate receptor agonist or a pharmaceutically acceptable salt or hydrate thereof are a therapeutic agent or prophylactic agent for an inflammatory bowel disease comprises.

  提供了一种针对炎症性肠病的新型治疗剂或预防剂。一种由通式(1)表示的氨基醇衍生物，该衍生物是一种神经酰胺-1-磷酸酯受体激动剂或其药用接受的盐或水合物，是治疗剂或预防剂，用于炎症性肠病。
• THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR DEMYELINATING DISEASE COMPRISING AMINO ALCOHOL DERIVATIVE AS ACTIVE INGREDIENT
  申请人：Kuriyama Kazuhiko

  公开号：US20100093745A1

  公开（公告）日：2010-04-15

  A novel therapeutic agent or prophylactic agent for a demyelinating disease is provided. An amino alcohol derivative represented by the general formula (1), which is a sphingosine-1-phosphate receptor agonist, a pharmacologically acceptable salt or hydrates thereof, are a therapeutic agent or prophylactic agent for a demyelinating disease.

  提供了一种新型治疗剂或预防剂，用于脱髓鞘疾病。一种由一般式（1）表示的氨基醇衍生物，它是一种鞘氨醇-1-磷酸受体激动剂，以及其药理学上可接受的盐或水合物，是脱髓鞘疾病的治疗剂或预防剂。
• AMINO PHOSPHATE DERIVATIVE AND S1P RECEPTOR MODULATOR HAVING SAME AS AN ACTIVE INGREDIENT
  申请人：Kohno Yasushi

  公开号：US20090325907A1

  公开（公告）日：2009-12-31

  To provide an amino phosphate derivative having an excellent sphingosine-1-phosphate (S1P) receptor modulatory action. As a result of continued intensive research to create a highly safe compound which has an S1P receptor modulatory action, is has been discovered that an amino phosphate derivative represented by the following general formula (1), has a strong S1P receptor modulatory action.

  提供一种具有优异的鞘氨醇-1-磷酸受体调节作用的氨基磷酸酯衍生物。通过持续的深入研究，以创造具有S1P受体调节作用的高度安全的化合物为目标，发现下述通式（1）所表示的氨基磷酸酯衍生物具有强烈的S1P受体调节作用。
• AMINO ALCOHOL DERIVATIVE AND IMMUNOSUPPRESIVE AGENT HAVING SAME AS AN ACTIVE INGREDIENT
  申请人：Kohno Yasushi

  公开号：US20100010000A1

  公开（公告）日：2010-01-14

  An amino alcohol derivative useful as an excellent immunosuppressive agent is provided. As a result of intensive research to create a highly safe compound which has an excellent immunosuppressive activity, it was discovered that an amino alcohol derivative represented by the general formula (1), has excellent immunosuppressive activity.

  提供了一种氨基醇衍生物，可作为优异的免疫抑制剂。通过进行深入研究以创建一种高度安全且具有优异免疫抑制活性的化合物，发现由通式（1）表示的氨基醇衍生物具有优异的免疫抑制活性。
• AMINOALCOHOL DERIVATIVE AND IMMUNOSUPPRESSANT CONTAINING THE SAME AS AN ACTIVE INGREDIENT
  申请人：Kyorin Pharmaceutical Co., Ltd.

  公开号：EP2053038A1

  公开（公告）日：2009-04-29

  An amino alcohol derivative useful as an excellent immunosuppressive agent is provided. As a result of intensive research to create a highly safe compound which has an excellent immunosuppressive activity, it was discovered that an amino alcohol derivative represented by the general formula (1), has excellent immunosuppressive activity.

  本发明提供了一种可用作优良免疫抑制剂的氨基醇衍生物。 经过深入研究，人们发现了一种由通式（1）表示的氨基醇衍生物，它是一种具有优异免疫抑制活性的高安全性化合物、 具有优异的免疫抑制活性。